ادامه مقالات در خصوص Covid-۱۹

 

Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements and Prognosis of COVID-19 Pneumonia Using Computed Tomography

SnapShot: COVID-19

Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Differentiating COVID-19 response strategies

Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults

Ongoing Clinical Trials for the Management of the COVID-19 Pandemic

COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Serological differentiation between COVID-19 and SARS infections

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial

"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Treating COVID-19 with Chloroquine

Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma

Nitazoxanide against COVID-19 in three explorative scenarios

COVID-19 mortality in patients on anticoagulants and antiplatelet agents

Interferon-α2b Treatment for COVID-19

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia